GlassScriptPhysician profile
Ian M Cohen
NPI 1437167210
$1,356.46
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,018 · 2020: $272 · 2021: $31.01 · 2022: $35.55.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $282.26 | 2019-2022 | |
| Amgen INC. | $277.06 | 2019-2020 | |
| Abbvie INC. | $202.98 | 2019 | |
| Radius Health, INC. | $118.22 | 2019 | |
| Therapeuticsmd, INC. | $116.36 | 2019-2020 | |
| Millicent US INC | $70.33 | 2019 | |
| Astellas Pharma US INC | $62.62 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $29.52 | 2019 | |
| Medtronic Vascular, INC. | $23.57 | 2019 | |
| Duchesnay USA Incorporated | $21.58 | 2019 | |
| Eisai INC. | $20.85 | 2020 | |
| Exeltis, USA INC. | $20.21 | 2019 | |
| Allergan, INC. | $19.50 | 2019 | |
| Urovant Sciences INC | $17.33 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.74 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $14.94 | 2019 | |
| Mylan Pharmaceuticals INC. | $14.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.27 | 2021 | |
| Vertical Pharmaceuticals, LLC | $13.37 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.